Al MJ - Search Results

1

The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands.

Goossens LM, Standaert B, Hartwig N, Hövels AM, Al MJ. Goossens LM, et al. Among authors: al mj. Vaccine. 2008 Feb 20;26(8):1118-27. doi: 10.1016/j.vaccine.2007.11.070. Epub 2007 Dec 17. Vaccine. 2008. PMID: 18215445

2

Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis.

Al MJ, Koopmanschap MA, van Enckevort PJ, Geertsma A, van der Bij W, de Boer WJ, TenVergert EM. Al MJ, et al. Chest. 1998 Jan;113(1):124-30. doi: 10.1378/chest.113.1.124. Chest. 1998. PMID: 9440579

3

Cost-utility of brief psychological treatment for depression and anxiety.

van Roijen LH, van Straten A, Al M, Rutten F, Donker M. van Roijen LH, et al. Br J Psychiatry. 2006 Apr;188:323-9. doi: 10.1192/bjp.188.4.323. Br J Psychiatry. 2006. PMID: 16582058 Clinical Trial.

4

Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands.

Al MJ, Maniadakis N, Grijseels EW, Janssen M. Al MJ, et al. Value Health. 2008 Jul-Aug;11(4):589-99. doi: 10.1111/j.1524-4733.2007.00303.x. Epub 2008 Jan 8. Value Health. 2008. PMID: 18194404 Free article.

5

A microcosting study of intensive care unit stay in the Netherlands.

Tan SS, Hakkaart-van Roijen L, Al MJ, Bouwmans CA, Hoogendoorn ME, Spronk PE, Bakker J. Tan SS, et al. Among authors: al mj. J Intensive Care Med. 2008 Jul-Aug;23(4):250-7. doi: 10.1177/0885066608318661. Epub 2008 May 28. J Intensive Care Med. 2008. PMID: 18508839 Review.

6

The cost utility of solifenacin in the treatment of overactive bladder.

Hakkaart L, Verboom P, Phillips R, Al MJ. Hakkaart L, et al. Among authors: al mj. Int Urol Nephrol. 2009;41(2):293-8. doi: 10.1007/s11255-008-9448-2. Epub 2008 Aug 15. Int Urol Nephrol. 2009. PMID: 18704742

7

Conclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions.

Goossens L, Standaert B, Hartwig N, Hövels AM, Al MJ. Goossens L, et al. Among authors: al mj. Vaccine. 2009 Apr 28;27(19):2531-2. doi: 10.1016/j.vaccine.2009.02.036. Epub 2009 Feb 20. Vaccine. 2009. PMID: 19428858 No abstract available.

8

Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands.

Al MJ, Hakkaart L, Tan SS, Bakker J. Al MJ, et al. Crit Care. 2010;14(6):R195. doi: 10.1186/cc9313. Epub 2010 Nov 1. Crit Care. 2010. PMID: 21040558 Free PMC article. Clinical Trial.

9

Comparing methods of data synthesis: re-estimating parameters of an existing probabilistic cost-effectiveness model.

Oppe M, Al M, Rutten-van Mölken M. Oppe M, et al. Pharmacoeconomics. 2011 Mar;29(3):239-50. doi: 10.2165/11539870-000000000-00000. Pharmacoeconomics. 2011. PMID: 21142288

10

Cost-Effectiveness of Including a Nurse Specialist in the Treatment of Urinary Incontinence in Primary Care in the Netherlands.

Holtzer-Goor KM, Gaultney JG, van Houten P, Wagg AS, Huygens SA, Nielen MM, Albers-Heitner CP, Redekop WK, Rutten-van Mölken MP, Al MJ. Holtzer-Goor KM, et al. Among authors: al mj. PLoS One. 2015 Oct 1;10(10):e0138225. doi: 10.1371/journal.pone.0138225. eCollection 2015. PLoS One. 2015. PMID: 26426124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters